Trial now
AUSSIE 10-YEAR TECHS

(Z1) Shallow Bounce

USDCAD TECHS

Trend Needle Still Points North

WHITE HOUSE

Biden Losing Support On COVID-19 Strategy: Poll

AUDUSD TECHS

Slide Accelerates

LATAM

Snapshot: USDMXN Set To Post Highest 2021 Close

EURJPY TECHS

Still Looking For Weakness

CHINA PRESS
MNI (Sydney)

China reported its first patent of a vaccine against the Covid-19 virus which can be mass-produced, the Beijing Youth Daily reported on Monday. Named Ad5-nCoV, the vaccine was developed by a research team led by Chen Wei at the Military Science Academy in conjunction with CanSino Biologics. The vaccine has proved its efficacy in previous trials and is entering phase III clinical trails, reported the Daily.

MNI Sydney Bureau | +61-405-322-399 | lachlan.colquhoun.ext@marketnews.com
MNI Sydney Bureau | +61-405-322-399 | lachlan.colquhoun.ext@marketnews.com